Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 50090-2519

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-2519). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500902180)

Venlafaxine Hydrochloride 75 mg extended-release capsules packaging label from A-S Medication Solutions. The label includes directions to store the capsules at 68 to 77 degrees Fahrenheit and specifies a quantity of 30 capsules per package. The label also notes the product number and National Drug Code (NDC) 50090-2180-0.*

FDA Label Image

Lbl500902281

Venlafaxine Hydrochloride 37.5 mg extended-release capsules packaging label. The label shows product number 6468-0 and contains 30 capsules. It is a human prescription drug by A-S Medication Solutions, with storage instructions to keep between 60 to 70 degrees Fahrenheit.*

FDA Label Image

Lbl500902519

Venlafaxine Hydrochloride 150 mg extended release capsules packaged by A-S Medication Solutions. The carton contains 30 capsules, with storage instructions to keep between 40 and 70 degrees Fahrenheit. The label includes the NDC code and batch information.*

FDA Label Image

Figure 1: Effect Of Interacting Drugs On The Pharmacokinetics Of Venlafaxine And Active Metabolite O-desmethylvenlafaxine (odv). (Venlafaxine Fig1)

A pharmacokinetic chart depicting the fold change and 90% confidence interval for venlafaxine and its O-desmethylvenlafaxine (ODV) metabolite when co-administered with various interacting drugs such as ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The x-axis shows change relative to a reference value, with recommendations on concomitant use and dose adjustment noted for each drug interaction.*

FDA Label Image

Figure 2: Effect Of Venlafaxine On The Pharmacokinetics Interacting Drugs And Their Active Metabolites. (Venlafaxine Fig2)

A chart depicting pharmacokinetic fold changes and 90% confidence interval recommendations for various interacting drugs when co-administered with a drug, showing changes in Cmax and AUC values. The x-axis represents fold change relative to a reference value, and annotations include dose adjustment advice or clinical significance notes for each drug analyte.*

FDA Label Image

Figure 3: Pharmacokinetics Of Venlafaxine And Its Metabolite O-desmethylvenlafaxine (odv) In Special Populations. (Venlafaxine Fig3)

A forest plot chart showing the effect of various special populations on venlafaxine pharmacokinetics, including hepatic impairment (cirrhosis, mild, moderate), renal impairment (mild/moderate, hemodialysis), CYP2D6 polymorphism, age over 60, and gender. The chart displays fold changes and 90% confidence intervals for Cmax and AUC parameters, along with dosing recommendations such as dose reductions or no adjustment needed.*

FDA Label Image

Chemical Structure (Venlafaxine Str)

Chemical structure diagram of venlafaxine hydrochloride, showing its molecular arrangement including a cyclohexane ring, methoxy group, dimethylamino group, and hydrochloride notation. The name venlafaxine hydrochloride is labeled below the structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.